Xiaoyi Wei Selected Research

Xiaoyi Wei Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 02/2012
3	Breast Neoplasms (Breast Cancer) 02/2023 - 02/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 01/2021
2	Constipation 04/2023 - 03/2023
2	Emergence Delirium 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2011
2	Necrosis 01/2021 - 11/2017
2	Non-alcoholic Fatty Liver Disease 01/2021 - 08/2009
1	Gestational Diabetes (Gestational Diabetes Mellitus) 04/2024
1	Inflammation (Inflammations) 11/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2023
1	Bites and Stings (Sting) 10/2022
1	Liposarcoma 09/2022
1	Urinary Fistula 08/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2022
1	Pathologic Constriction (Stenosis) 08/2022
1	Fistula 08/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Acute-On-Chronic Liver Failure 01/2022
1	Hyperglycemia 01/2022
1	Insulin Resistance 01/2022
1	Infections 01/2021
1	Human Influenza (Influenza) 01/2021
1	Cicatrix (Scar) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Pain (Aches) 01/2021
1	Schistosomiasis (Bilharziasis) 01/2021
1	Confusion (Bewilderment) 01/2021
1	Liver Failure 01/2020
1	Carcinogenesis 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Nasopharyngeal Carcinoma 07/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2011
1	Lung Neoplasms (Lung Cancer) 06/2011

Drug/Important Bio-Agent (IBA)

3	EnzymesIBA 11/2023 - 02/2012
3	AcidsIBA 03/2023 - 02/2012
3	CytokinesIBA 10/2022 - 03/2014
2	AntibodiesIBA 10/2022 - 01/2022
2	Bispecific AntibodiesIBA 01/2022 - 01/2021
2	AntigensIBA 01/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2022 - 10/2011
2	HMGB1 Protein (HMG1)IBA 01/2022 - 01/2020
2	LipopolysaccharidesIBA 01/2021 - 11/2017
2	Anthocyanins (Anthocyanin)IBA 04/2011 - 12/2010
2	Triglycerides (Triacylglycerol)IBA 04/2011 - 08/2009
1	CollagenIBA 02/2024
1	Leucine (L-Leucine)FDA Link 02/2024
1	tetrahydrocurcuminIBA 01/2024
1	CurcuminIBA 01/2024
1	Ethanol (Ethyl Alcohol)IBA 10/2023
1	Ergosterol (Lumisterol)IBA 06/2023
1	ChitosanIBA 04/2023
1	Biotin (Vitamin H)FDA Link 02/2023
1	squamocinIBA 02/2023
1	CD19 AntigensIBA 10/2022
1	blinatumomabIBA 10/2022
1	VimentinIBA 09/2022
1	EpitopesIBA 01/2022
1	Selenoprotein PIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	RamucirumabIBA 01/2022
1	SeleniumIBA 01/2022
1	PeroxidasesIBA 01/2022
1	HomocysteineIBA 01/2022
1	Selenoproteins (Selenoprotein)IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	astragaloside AIBA 01/2022
1	Neuraminidase (Sialidase)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	GalactosamineIBA 01/2021
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Praziquantel (Biltricide)FDA Link 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	shigyaku-san (Si-Ni-San)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	PolyketidesIBA 01/2018
1	Dronabinol (THC)FDA LinkGeneric 12/2017
1	pyrazoleIBA 12/2017
1	2,5-dichloro-4-bromophenol (B 2)IBA 11/2016
1	9-hydroxymegastigman-4-en-3-one 9-O-beta-D-glucopyranosideIBA 07/2016
1	monorden (radicicol)IBA 02/2012
1	Cyclin-Dependent Kinase 2IBA 02/2012
1	LactonesIBA 02/2012
1	monocillin IIIBA 02/2012
1	AntioxidantsIBA 06/2011
1	Oxidoreductases (Dehydrogenase)IBA 06/2011

Therapy/Procedure

4	Therapeutics 02/2024 - 10/2011
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2021
1	Nutrition Therapy (Medical Nutrition Therapy) 04/2024
1	Conservative Treatment 08/2022
1	Urinary Diversion (Ileal Conduit) 08/2022
1	Cystectomy 08/2022
1	General Anesthesia 01/2022
1	Length of Stay 01/2021
1	Activities of Daily Living (ADL) 01/2021